TPG biotech team invests in Sleep Solutions

The TPG Biotechnology II fund has led a $20.5 million round of financing in a sleep disorder company.

BySuzanne Weinstock

4 January 2013•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Latin America North America